TokenPost·
Moderna Shares Rise 13% Ahead of Third-Quarter Results Friday
The WHO vaccine advisory group recommended adding mRNA-1469 to an ongoing Phase 2/3 Ebola trial. Data for a separate cancer therapy are slated for an oral presentation.
More news
- TokenPostBitcoin spot ETF net assets reach $102.26 billion as daily inflows total $74.57 million
- TokenPostBlackRock ETHA draws $32.75 million as Ethereum spot ETFs post $53.02 million inflow
- Crypto BriefingSpot Bitcoin ETFs see $75M in net inflows as BlackRock’s IBIT sheds $201M
- TokenPostPolkadot Proposal Would Cut Active Validator Set to 320 by Year-End
- TokenPostMITT.PR.A Quarterly Dividend Holds at $0.5156 Per Share
- CoinDeskBitcoin holds above $80,000 as Zcash jumps 12% in post-election crypto rebound